Accordingly, the results of numerous genome-wide association studies (GWAS) and clinical trials support the central role of the inflammatory signaling molecular pathways of TNF-α, IL-23, and IL-17 as the “founding fathers” of the pathogenesis of psoriasis, particularly plaque psoriasis [14,22,23,24]. Here, IL17A is linked to psoriasis.